Department of Health

Onconova Therapeutics Announces the Appointment of Mark Gelder, M.D., as Chief Medical Officer

Retrieved on: 
Tuesday, June 1, 2021
Government, Department of Health, Chief Medical Officers, Civil service, Government of Northern Ireland, Government of Scotland, Health in the United Kingdom, Chief Medical Officer, Articles

will be joining Onconova as Chief Medical Officer (CMO), effective as of June 14, 2021.

Key Points: 
  • will be joining Onconova as Chief Medical Officer (CMO), effective as of June 14, 2021.
  • He will add great depth to our management team, said Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova.
  • I am thrilled that Mark will be joining Onconova and eager to begin working together.
  • Dr. Gelder is an accomplished industry leader with more than 35 years of experience in clinical development, medical affairs, and medical marketing.

Dr. Francisco Ward named Chief Medical Officer of Bazelet Health Systems

Retrieved on: 
Thursday, April 8, 2021
Government, Chief Medical Officer, Department of Health, Chief Medical Officer, Articles

COLUMBIA,Md., April 8, 2021 /PRNewswire/ -- Neon Bloom, Inc. (OTC: NBCO) -- Bazelet Health Systems, Inc. ("BHS") introduces Board Certified Dr. Francisco Ward as their new chief medical officer (CMO).

Key Points: 
  • COLUMBIA,Md., April 8, 2021 /PRNewswire/ -- Neon Bloom, Inc. (OTC: NBCO) -- Bazelet Health Systems, Inc. ("BHS") introduces Board Certified Dr. Francisco Ward as their new chief medical officer (CMO).
  • Dr. Francisco Ward, graduate of Johns Hopkins School of Medicine named Chief Medical Officer of Bazelet Health Systems.
  • As CMO, Dr. Ward will manage relationships with US healthcare entities, insurers, regulators and the global medical and research community.
  • Selected as a greater Baltimore region "Top Doc", Dr. Ward has served as Maryland State Medical Society chair of the medical cannabis Task Force.

Statement of the National Alliance for Hispanic Health on Historic Confirmation of Xavier Becerra as Nation's 25th Secretary of Health and Human Services

Retrieved on: 
Thursday, March 18, 2021
Jane Delgado, National Alliance for Hispanic Health, United States Secretary of Health and Human Services, Health department, United States Department of Health and Human Services, DHHS, Department of Health

We welcome this historic confirmation and look forward to working with Secretary Becerra to ensure the best health for all," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic health, the nation's leading Hispanic health advocacy group.

Key Points: 
  • We welcome this historic confirmation and look forward to working with Secretary Becerra to ensure the best health for all," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic health, the nation's leading Hispanic health advocacy group.
  • "Under his leadership, the Department of Health and Human Services (DHHS) will lead the COVID response in a way that recognizes the sacrifices and losses that so many have endured and create a new path forward.
  • As the first Hispanic Secretary of Health and Human Services, his example will continue to be a beacon of achievement and possibility for all and especially for the next generation of Hispanic leadership," concluded Dr. Delgado.
  • The Alliance is the nation's foremost science-based source of information and trusted advocate for the health of Hispanics in the United States with a mission to achieve the best health for all.

Envistacom a Prime for $2B CIO-SP3 IT Solutions and Services Contract

Retrieved on: 
Thursday, March 11, 2021
Technology, Other Defense, Contracts, Semiconductor, Security, Satellite, Telecommunications, Software, Networks, Defense, Government procurement in the United States, General Services Administration, IDIQ, Health, Government, National Institutes of Health, Department of Health, National Institute of Health, Islamabad, Governmentwide Acquisition Contracts

The CIO-SP3 indefinite delivery, indefinite quantity (IDIQ) contract supports the National Institute of Health (NIH), the Department of Health and Human Services (DHHS), and other federal agencies.

Key Points: 
  • The CIO-SP3 indefinite delivery, indefinite quantity (IDIQ) contract supports the National Institute of Health (NIH), the Department of Health and Human Services (DHHS), and other federal agencies.
  • As part of the contract, Envistacom will provide IT and other telecom services and solutions specific to health, health science, and biomedical-related areas.
  • Envistacom is proud to partner with the NIH, DHHS, and other federal agencies to meet their CIO-SP3 IT solutions needs, said Alan Carson, President, Envistacom.
  • For more information on solutions or contract vehicles, please visit www.envistacom.com , and follow @Envistacom on Facebook, Twitter, LinkedIn and YouTube.

The Harris Center for Mental Health and IDD Partners with Ascend HR Corp for Chief Medical Officer Search

Retrieved on: 
Tuesday, March 9, 2021
Chief Medical Officer, Department of Health, Developmental disability, Chief Medical Officer, Articles

HOUSTON, March 9, 2021 /PRNewswire-PRWeb/ -- Ascend HR Corp, the parent company of HR Maximizer Inc, a leading healthcare recruitment firm, has been tasked with leading the search for a Chief Medical Officer (CMO) for the Harris Center for Mental Health and Intellectual and Developmental Disabilities (IDD).

Key Points: 
  • HOUSTON, March 9, 2021 /PRNewswire-PRWeb/ -- Ascend HR Corp, the parent company of HR Maximizer Inc, a leading healthcare recruitment firm, has been tasked with leading the search for a Chief Medical Officer (CMO) for the Harris Center for Mental Health and Intellectual and Developmental Disabilities (IDD).
  • We want to cast a broad net to be able to find that right candidate," said Wayne Young, CEO for the Harris Center.
  • Scott Rule, Chief Business Officer for the Harris Center stated, "I'd like to see a CMO that has energetic compassion.
  • "The Harris Center is an organization where the employees have big hearts and brilliant minds," added Lesleigh Robertson, VP of HR and Organizational Development.

Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision

Retrieved on: 
Thursday, February 4, 2021
Gene therapy, Chief Medical Officer, Department of Health, Chief Medical Officer, Voretigene neparvovec, Articles

Former Spark Therapeutics head of ophthalmic medical affairs, responsible for the development and approval of Luxturna, to lead development of SparingVisions proprietary asset, SPVN06, and further pipeline development

Key Points: 
  • Former Spark Therapeutics head of ophthalmic medical affairs, responsible for the development and approval of Luxturna, to lead development of SparingVisions proprietary asset, SPVN06, and further pipeline development
    Paris, February 04, 2021 SparingVision (the Company), a genomic medicine company developing vision saving treatments for ocular diseases, today announces the appointment of Dr Daniel C. Chung as Chief Medical Officer (CMO).
  • He also later led the medical affairs group responsible for its safe and efficient use in patients.
  • Based in the U.S., Dr. Chung will also lead the education of the medical and patient communities on SparingVisions unique and game-changing mutation-agnostic approach in gene therapy.
  • Dr Daniel C. Chung, Chief Medical Officer of SparingVision, added, SparingVisions pioneering science and the teams track record in drug development, manufacturing and building of successful companies is impressive.

Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision

Retrieved on: 
Thursday, February 4, 2021
Gene therapy, Chief Medical Officer, Department of Health, Chief Medical Officer, Voretigene neparvovec, Articles

Former Spark Therapeutics head of ophthalmic medical affairs, responsible for the development and approval of Luxturna, to lead development of SparingVisions proprietary asset, SPVN06, and further pipeline development

Key Points: 
  • Former Spark Therapeutics head of ophthalmic medical affairs, responsible for the development and approval of Luxturna, to lead development of SparingVisions proprietary asset, SPVN06, and further pipeline development
    Paris, February 04, 2021 SparingVision (the Company), a genomic medicine company developing vision saving treatments for ocular diseases, today announces the appointment of Dr Daniel C. Chung as Chief Medical Officer (CMO).
  • He also later led the medical affairs group responsible for its safe and efficient use in patients.
  • Based in the U.S., Dr. Chung will also lead the education of the medical and patient communities on SparingVisions unique and game-changing mutation-agnostic approach in gene therapy.
  • Dr Daniel C. Chung, Chief Medical Officer of SparingVision, added, SparingVisions pioneering science and the teams track record in drug development, manufacturing and building of successful companies is impressive.

Florida's Bureau of Public Health Laboratories Selects MedicsPremier from Advanced Data Systems for Comprehensive Billing, Financial, and Data Analytics Requirements

Retrieved on: 
Thursday, November 19, 2020
Department of Health, Health in the Philippines, Health department, Paramus, New Jersey, Health Canada, Government, Health

PARAMUS, N.J., Nov. 19, 2020 /PRNewswire/ --The Florida Department of Health's Bureau of Public Health Laboratories has selected the MedicsPremier system from Advanced Data Systems Corp. ( ADS ) to handle the Bureau's extensive billing, financial, and reporting requirements.

Key Points: 
  • PARAMUS, N.J., Nov. 19, 2020 /PRNewswire/ --The Florida Department of Health's Bureau of Public Health Laboratories has selected the MedicsPremier system from Advanced Data Systems Corp. ( ADS ) to handle the Bureau's extensive billing, financial, and reporting requirements.
  • Thousands of claims daily from across the entire state's public health laboratories will be processed through MedicsPremier.
  • The Bureau is discontinuing its current system as inadequate for the volume of claims now needed, and the much more extensive reporting they require.
  • Jennifer Martin, Administrative Services Director, Florida Department of Health, Bureau of Public Health Laboratories, Division of Disease Control and Health Protection, said, "The system we were using for years became obsolete.

Aveshka announces Dr. Til Jolly as Chief Medical Officer

Retrieved on: 
Monday, August 10, 2020
Government, Chief Medical Officer, Department of Health, Jolley, Chief Medical Officer, Articles

WASHINGTON, Aug. 10, 2020 /PRNewswire/ -- Aveshka announced Dr. Til Jolly will join the company's executive team as the Chief Medical Officer (CMO).

Key Points: 
  • WASHINGTON, Aug. 10, 2020 /PRNewswire/ -- Aveshka announced Dr. Til Jolly will join the company's executive team as the Chief Medical Officer (CMO).
  • Dr. Jolly is a board-certified emergency physician with a wide range of experience in the government and private sector.
  • As CMO, Dr. Jolly will directly support clients by providing clinical leadership and direction for all public health and healthcare matters.
  • "Dr. Jolly will no doubt be a crucial component of Aveshka's important work in public health and emergency management," said Girish Jindia, Aveshka President and CEO.

Vave Health Appoints Dr. Renee Dversdal as Chief Medical Officer

Retrieved on: 
Monday, July 27, 2020
Acoustics, Chief Medical Officer, Department of Health, Vave, Ultrasound, Medical ultrasonography

SANTA CLARA, Calif., July 27, 2020 /PRNewswire/ -- Vave Health , a maker of innovative handheld ultrasound technology, today announced Dr. Renee Dversdal as its chief medical officer.

Key Points: 
  • SANTA CLARA, Calif., July 27, 2020 /PRNewswire/ -- Vave Health , a maker of innovative handheld ultrasound technology, today announced Dr. Renee Dversdal as its chief medical officer.
  • Dr. Dversdal joins the executive team to lead the company's clinical development and medical affairs activities and to further advance Vave Health's mission in delivering easily accessible, high-quality medical technology to patients and medical professionals.
  • Dr. Dversdal is a published clinician and provides more than a decade of experience to her role as chief medical officer.
  • "I am passionate about increasing access to point-of-care diagnostic imagingand Vave's wireless ultrasound technology is exactly what I've been asking from the industry for years," said Dr. Renee Dversdal, chief medical officer, Vave Health.